In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031

icon1
USD 20.97 BN
MARKET SIZE, 2031
icon2
CAGR 10.6%
(2026-2031)
icon3
500
REPORT PAGES
icon4
550
MARKET TABLES

OVERVIEW

in-vitro-toxicology-testing-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global in vitro toxicology testing market is projected to reach USD 20.97 billion by 2031, growing from USD 12.69 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. This growth is driven by several factors, including a regulatory and ethical shift away from animal testing, particularly in the cosmetics, chemicals, and drug safety evaluation sectors. Additionally, the adoption of advanced human-relevant models, such as 3D cultures, organoids, and microphysiological systems, is improving predictivity. Furthermore, the rising trend of outsourcing toxicology workflows by pharmaceutical, biotech, chemical, and consumer care companies is also contributing to market expansion.

KEY TAKEAWAYS

  • By Region
    North America accounted for the largest market share of 39.3% in 2025.
  • By Offering
    By offering, the products segment accounted for a larger share than the services segment in 2025.
  • Product, By Type
    By type, the reagents & consumables segment dominated the in vitro toxicology products market, with a share of 27.8% in 2025.
  • Product, By Toxicity Endpoint and Test
    By toxicity endpoint and test, the organ toxicity testing segment dominated the in vitro toxicology products market in 2025.
  • Product, By Technology
    By technology, the cell culture technologies segment dominated the in vitro toxicology products market in 2025.
  • Product, By Method
    By method, the cell-based toxicity testing method dominated the in vitro toxicology products market in 2025.
  • Product, By End User
    By end user, the pharmaceuticals & biotechnology companies segment dominated the in vitro toxicology products market in 2025.
  • Service, By Type
    By type, the toxicology testing service segment dominated the in vitro toxicology services market in 2025.
  • Service, By Method
    By method, the cell-based toxicity testing method segment dominated the in vitro toxicology services market in 2025.
  • Service, By End User
    By end user, the pharmaceuticals & biotechnology companies segment dominated the in vitro toxicology services market in 2025.
  • Competitive Landscape - Key Players
    Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Agilent Technologies, Inc. (US) were identified as star players in the global in vitro toxicology testing market, given their strong market share and product and service footprint.
  • Competitive Landscape - Startups/SMEs
    Intertek Group plc (UK) and Creative Bioarray (US) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global in vitro toxicology testing market is steadily growing due to several factors. There is increasing regulatory and ethical pressure to minimize animal testing, as well as a rising demand for faster and more relevant preclinical safety assessments in the pharmaceutical, biopharmaceutical, consumer care, chemicals, and food industries. Additionally, there is a growing adoption of advanced techniques, such as cell-based models, 3D cultures, organoids, and high-throughput toxicity screening technologies, which are being utilized in research, product development, and regulatory testing workflows.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The in vitro toxicology testing market is progressing steadily, fueled by innovations in cell-based assays, 3D cell culture models, organoids, organ-on-chip platforms, high-content screening, automation, and predictive toxicology tools. There is a rising demand for faster, human-relevant, and non-animal safety assessments across various sectors, including pharmaceuticals, biotechnology, cosmetics, chemicals, food, and medical devices. This demand is accelerating the adoption of in vitro testing workflows. Additionally, the market is supported by evolving regulatory expectations, an increasing replacement of animal testing, and a growing trend of outsourcing toxicity studies to specialized contract research organizations (CROs).

in-vitro-toxicology-testing-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing industry shift toward non-animal toxicology testing methods
  • Increasing technological advancements
RESTRAINTS
Impact
Level
  • Limited in vivo-to-in vitro correlation for complex endpoints
OPPORTUNITIES
Impact
Level
  • AI/ML-powered predictive toxicology
  • Increasing focus on drug discovery using in vitro methods
CHALLENGES
Impact
Level
  • Ethical and regulatory challenges in AI-driven toxicology

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing industry shift toward non-animal toxicology testing methods

A growing regulatory, ethical, and scientific movement aimed at reducing animal testing is driving the adoption of in vitro toxicology testing across various industries, including pharmaceuticals, cosmetics, chemicals, food, and medical devices. Companies are increasingly utilizing cell-based assays, 3D tissue models, organoids, and organ-on-chip platforms to produce faster and more human-relevant safety data, thereby enhancing early-stage toxicity predictions.

Restraint: Limited in vivo-to-in vitro correlation for complex endpoints

While in vitro models have seen significant adoption, they may not completely replicate the biological responses of a whole body. This includes aspects such as metabolism, immune interactions, chronic exposure, reproductive toxicity, and effects across multiple organs. As a result, there is limited regulatory confidence for certain complex endpoints. To address these limitations, additional evidence is often needed from computational models, ex vivo systems, or limited in vivo studies.

Opportunity: AI/ML-powered predictive toxicology

Artificial intelligence (AI) and machine learning are creating significant opportunities by enabling predictive toxicity modeling, high-content image analysis, QSAR-based screening, multi-omics interpretation, and faster prioritization of compounds. These tools help reduce the experimental burden, enhance early risk detection, and support more efficient non-animal safety assessment workflows.

Challenge: Ethical and regulatory challenges in AI-driven toxicology

AI-driven toxicology encounters several challenges, including issues with data quality, model transparency, bias, validation, explainability, and regulatory acceptance. Because safety decisions demand a high level of confidence and reproducibility, companies must ensure that AI models are scientifically validated, traceable, and in alignment with evolving regulatory expectations before they can be widely used in decision-making.

IN VITRO TOXICOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers cytotoxicity and cell-viability products, such as LIVE/DEAD assays, LDH assays, alamarBlue, and ROS detection kits for compound toxicity screening Supports rapid cell damage, viability, oxidative stress, and drug-discovery toxicity assessment
Provides CellTiter-Glo 3D assay for viability testing in 3D microtissue/spheroid toxicity models Improves cytotoxicity readouts in 3D cultures and supports high-throughput screening

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The in vitro toxicology testing market ecosystem comprises product and service providers such as Thermo Fisher Scientific, Merck, Lonza, Charles River, and Agilent Technologies; raw material suppliers, such as BASF, Dow, and Evonik; regulatory bodies including the FDA, EMA, MHRA, and PMDA, among others; and end users such as Pfizer, Amgen, and Novartis. Product and service providers supply assay kits, reagents, consumables, instruments, cell-based models, analytical platforms, and outsourced toxicology testing services. Raw material suppliers support the market through chemicals, specialty materials, media components, and testing inputs used in assay development and laboratory workflows. Regulatory agencies play a central role by guiding safety assessment requirements and encouraging validated non-animal testing approaches. End users rely on IVTT solutions for early toxicity screening, drug discovery, preclinical safety assessment, chemical safety evaluation, and regulatory submissions. Collaborative partnerships across this ecosystem are critical for improving test predictivity, reducing animal use, accelerating timelines, and supporting growth in a market projected to expand steadily over the forecast period

in-vitro-toxicology-testing-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

in-vitro-toxicology-testing-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Global In Vitro Toxicology Testing Market, by Offering

The products segment accounted for the largest share in 2025, driven by recurring demand for assay kits, reagents, media, consumables, cell models, and instruments used across routine toxicity workflows.

Product Market, by Type

The reagents & consumables segment accounted for the largest share in 2025, due to repeated use of assay reagents, media, sera, buffers, plates, detection substrates, and validated cell culture materials.

Product Market, by Toxicity Endpoint and Test

The organ toxicity testing segment led the product market in 2025, supported by strong use of hepatotoxicity, cardiotoxicity, ocular toxicity, and neurotoxicity assays in early safety screening.

Product Market, by Technology

The cell culture technologies segment dominated the market in 2025 due to the broad use of 2D/3D cell models, cell lines, media, and viability assays across cytotoxicity and organ toxicity testing.

Product Market, by Method

The cell-based toxicity testing segment accounted for the largest share in 2025, as cellular assays remain core to in vitro safety evaluation and compound profiling.

Product Market, by End User

The pharmaceutical & biotechnology companies segment led the demand in 2025 due to extensive use of IVTT products in discovery, preclinical screening, and safety pharmacology workflows.

Service Market, by Type

The toxicology testing services segment dominated the market in 2025, supported by the outsourcing of cytotoxicity, genotoxicity, dermal, ocular, and organ-specific toxicity studies to CROs.

Service Market, by Method

The cell-based toxicity testing services segment accounted for the largest share in 2025 due to routine adoption across drug, cosmetic, chemical, and medical device safety testing.

Service Market, by End User

The pharmaceutical & biotechnology companies segment dominated market in 2025, driven by outsourcing of early toxicity screening and regulatory-supportive safety studies.

REGION

Asia Pacific to be fastest-growing market during forecast period

Asia Pacific is expected to experience the fastest growth in the in vitro toxicology testing market. This growth is supported by the expansion of research and development in the pharmaceutical and biotechnology sectors; increased activity from contract research organizations (CROs); a rise in drug discovery programs; and a broader adoption of cell-based assays, cytotoxicity screening, dermal toxicity testing, and high-throughput in vitro platforms across countries such as China, India, Japan, South Korea, and Australia. Additionally, regional growth is fueled by a rising demand for non-animal and cost-effective safety testing; an expanding focus on chemical and cosmetics safety assessments; increased life sciences research backed by academic institutions and government funding; as well as the growing availability of advanced assay kits, cell models, reagents, and contract testing services.

in-vitro-toxicology-testing-market Region

IN VITRO TOXICOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX

Thermo Fisher Scientific is a key player in the in vitro toxicology testing market, bolstered by its extensive portfolio, which includes cell culture media, reagents, assay kits, analytical instruments, high-content screening tools, and lab informatics. These offerings support various workflows such as cytotoxicity, genotoxicity, organ toxicity, and mechanistic toxicity. The company’s strong global distribution network, established relationships with pharmaceutical and biotech clients, automation capabilities, and integrated laboratory ecosystem further enhance its leadership in in vitro toxicology testing products and workflow solutions. In contrast, Bio-Rad Laboratories can be identified as an emerging leader in the in vitro toxicology testing market. Its strengths lie in life science research tools, cell analysis, assay systems, imaging, PCR, antibodies, reagents, and analytical platforms.

in-vitro-toxicology-testing-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 11.71 billion
Market Forecast in 2026 (Value) USD 12.69 billion
Market Forecast in 2031 (Value) USD 20.97 billion
Growth Rate 10.6%
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering {Products [Reagents & Consumables (Cell Lines & Primary Cells, Culture Reagents, Media & Consumables, 3D Models and Tissue Systems, Other Reagents & Consumables), Assay Kits (Cytotoxicity Assay, Genotoxicity Assay, Organ-Specific Toxicity Assay, Other Assays), Equipment (Detection, Imaging & Analytical Systems (Imaging Systems, Detection Instruments, Other Instruments), Liquid Handling & Automation Systems, Other Equipment), Software & Informatics, and Services
  • Product - By Toxicity End Point (Organ Toxicity Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity and Skin Irritation, Corrosion and Sensitization, Oxidative Stress and Mechanistic Toxicity, Other Toxicity Endpoints and Tests)
  • Product - By Technology (Cell Culture Technologies, High-Throughput and High-Content Technologies, Omics Technologies, Organotypic and Microphysiological Based Technologies, Other Technologies)
  • Product - By Method (Cell-Based Toxicity Testing Method, Biochemical Toxicity Testing Method, In Silico/Computational Toxicity Testing Method, Ex Vivo Models-Based Toxicity Testing Method, Molecular & Omics-Based Toxicology Method, Other Methods)
  • Product - By End User (Pharmaceuticals & Biotechnology Companies, Consumer Care Companies, Food & Beverages Companies, Cros, Academic And Research Institutes, Other End Users)
  • Service - By Type (Toxicology Testing Service, Biological Model And Assay Development Services, Imaging and Analytical Toxicology Services, Data Analysis, Bioinformatics, And Predictive Toxicology)
  • Service - By Method (Cell-based Toxicity Testing Method, Biochemical Toxicity Testing Method, In Silico/Computational Toxicity Testing Method, Ex Vivo Models-based Toxicity Testing Method, Molecular & Omics-based Toxicology Method, Other Methods)
  • Service - By End User (Pharmaceuticals & Biotechnology Companies, Consumer Care Companies, Food & Beverage Companies, Academic and Research Institutes, Other End Users)
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa

WHAT IS IN IT FOR YOU: IN VITRO TOXICOLOGY TESTING MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE

in-vitro-toxicology-testing-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Evaluate competitive positioning of key players in the in vitro toxicology testing market Benchmarked leading companies across assay kits, reagents & consumables, equipment, software, cell-based models, 3D tissue models, organ-on-chip platforms, and toxicology testing services based on technology portfolio, endpoint coverage, regulatory alignment, geographic reach, and end-user focus Identifies competitive gaps, portfolio white spaces, partnership opportunities, and differentiation strategies
Assess high-growth testing technologies and service opportunities Evaluated growth potential across cell-based assays, 3D cell culture, organoids, microphysiological systems, high-throughput screening, predictive toxicology, bioinformatics, and outsourced toxicology testing services across pharma, biotech, chemicals, cosmetics, food, and medical devices Supports investment prioritization, product development, CRO/service expansion, and technology adoption strategies

RECENT DEVELOPMENTS

  • October 2025 : Charles River announced a collaboration with Toxys to validate NAMs, including advanced in vitro assays for toxic, carcinogenic, and reproductive toxicity properties.
  • June 2025 : Emulate launched the AVA Emulation System, a high-throughput organ-chip platform with built-in incubation, automated imaging, and AI-ready data generation for scalable drug development studies.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
60
2
EXECUTIVE SUMMARY
 
 
 
 
 
64
3
PREMIUM INSIGHTS
 
 
 
 
 
69
4
MARKET OVERVIEW
Non-animal testing and AI advancements redefine toxicology amid rising R&D costs and ethical challenges.
 
 
 
 
 
72
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
GROWING INDUSTRY SHIFT TOWARD NON-ANIMAL TOXICOLOGY TESTING METHODS
 
 
 
 
 
 
4.2.1.2
INCREASING TECHNOLOGICAL ADVANCEMENTS
 
 
 
 
 
 
4.2.1.3
RISING PHARMACEUTICAL R&D EXPENDITURE AND DRUG ATTRITION COSTS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
LIMITED IN VIVO-TO-IN VITRO CORRELATION FOR COMPLEX ENDPOINTS
 
 
 
 
 
 
4.2.2.2
HIGH COST OF ADVANCED PLATFORMS (ORGAN-ON-CHIP, 3D MODELS)
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
AI/ML-POWERED PREDICTIVE TOXICOLOGY
 
 
 
 
 
 
4.2.3.2
INCREASING FOCUS ON DRUG DISCOVERY USING IN VITRO METHODS
 
 
 
 
 
 
4.2.3.3
CANNABIS, E-CIGARETTE, AND NOVEL PRODUCT SAFETY TESTING
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
ETHICAL AND REGULATORY CHALLENGES IN AI-DRIVEN TOXICOLOGY
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive forces and macroeconomic shifts reshaping global in vitro toxicology testing.
 
 
 
 
 
79
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2025
 
 
 
 
 
 
5.5.2
INDICATIVE SELLING PRICE, BY REGION, 2025
 
 
 
 
 
5.6
KEY CONFERENCES & EVENTS
 
 
 
 
 
 
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.8
INVESTMENT/FUNDING ACTIVITY
 
 
 
 
 
 
5.9
IMPACT OF 2025 TARIFFS—IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
 
5.9.1
INTRODUCTION
 
 
 
 
 
 
5.9.2
KEY TARIFF RATES
 
 
 
 
 
 
5.9.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.9.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.9.4.1
NORTH AMERICA
 
 
 
 
 
 
5.9.4.2
EUROPE
 
 
 
 
 
 
5.9.4.3
ASIA PACIFIC
 
 
 
 
 
5.9.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.9.5.1
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.9.5.2
CROS
 
 
 
 
 
 
5.9.5.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations reshape in vitro toxicology testing, unlocking new market potential and patent landscapes.
 
 
 
 
 
93
 
6.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
CELL CULTURE TECHNOLOGIES
 
 
 
 
 
 
6.1.2
OMICS TECHNOLOGIES
 
 
 
 
 
6.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
COMPUTATIONAL TOXICOLOGY AND AI
 
 
 
 
 
6.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
LAB-ON-A-CHIP (LOC)/ORGAN-ON-A-CHIP (OOC) SYSTEMS
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR IN VITRO TOXICOLOGY TESTING PATENTS, 2015–2025
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate evolving global regulations to align sustainability strategies with compliance and eco-certification standards.
 
 
 
 
 
102
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
7.1.3
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
7.3
CERTIFICATIONS, LABELING, & ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Uncover decision dynamics and unmet needs shaping buyer behavior across industries.
 
 
 
 
 
110
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
9
IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
114
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
GROWING ADOPTION OF ADVANCED ASSAY PRODUCTS TO SUPPORT GROWTH
 
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
INCREASING FOCUS ON OUTSOURCING TOXICOLOGY TO AID GROWTH
 
 
 
 
10
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 131 Data Tables
 
 
 
 
 
123
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
REAGENTS & CONSUMABLES
 
 
 
 
 
 
 
10.2.1
CULTURE REAGENTS, MEDIA, AND CONSUMABLES
 
 
 
 
 
 
 
10.2.1.1
INCREASING ADOPTION OF IVTT WORKFLOWS AND RECURRING USE OF REAGENTS TO SUPPORT GROWTH
 
 
 
 
 
10.2.2
3D MODELS & TISSUE SYSTEMS
 
 
 
 
 
 
 
10.2.2.1
SUPPORT FROM REGULATORY AGENCIES AND WIDE USAGE TO DRIVE MARKET GROWTH
 
 
 
 
 
10.2.3
CELL LINES & PRIMARY CELLS
 
 
 
 
 
 
 
10.2.3.1
EMPHASIS ON PERSONALIZED MEDICINE AND DRIVING QUALITY IMPROVEMENT IN COMMERCIALLY AVAILABLE CELLS TO PROPEL MARKET
 
 
 
 
 
10.2.4
OTHER REAGENTS & CONSUMABLES
 
 
 
 
 
10.3
ASSAY KITS
 
 
 
 
 
 
 
10.3.1
ORGAN-SPECIFIC TOXICITY ASSAYS
 
 
 
 
 
 
 
10.3.1.1
MARKET IS DRIVEN WELL-DOCUMENTED FAILURE OF GENERIC CYTOTOXICITY SCREENS TO PREDICT ORGAN-LEVEL ADVERSE EFFECTS
 
 
 
 
 
10.3.2
CYTOTOXICITY ASSAYS
 
 
 
 
 
 
 
10.3.2.1
CYTOTOXICITY ASSAYS ARE THE MOST UNIVERSALLY APPLIED ASSAYS IN IVTT
 
 
 
 
 
10.3.3
GENOTOXICITY ASSAYS
 
 
 
 
 
 
 
10.3.3.1
STRINGENT REGULATORY MANDATES TO SUPPORT GROWTH
 
 
 
 
 
10.3.4
OTHER ASSAYS
 
 
 
 
 
10.4
EQUIPMENT
 
 
 
 
 
 
 
10.4.1
DETECTION, IMAGING, AND ANALYTICAL SYSTEMS
 
 
 
 
 
 
 
10.4.1.1
DETECTION INSTRUMENTS
 
 
 
 
 
 
 
 
10.4.1.1.1
GROWTH IS SUPPORTED BY THE INCREASING VOLUME OF HTS WORKFLOWS IN PHARMACEUTICAL R&D AND EXPANDING USE OF FUNCTIONAL SAFETY PHARMACOLOGY ASSAYS
 
 
 
 
10.4.1.2
IMAGING SYSTEMS
 
 
 
 
 
 
 
 
10.4.1.2.1
DEMAND FOR IMAGING SYSTEMS IN IVTT IS BEING DRIVEN BY THE TRANSITION FROM SINGLE-ENDPOINT TO MULTIPARAMETRIC, IMAGE-BASED TOXICITY ASSESSMENT
 
 
 
 
10.4.1.3
OTHER INSTRUMENTS
 
 
 
 
 
 
10.4.1.4
LIQUID HANDLING & AUTOMATION SYSTEMS
 
 
 
 
 
 
 
 
10.4.1.4.1
EASE OFFERED BY AUTOMATION AND THE IMPORTANT ROLE OF LIQUID HANDLING IN WORKFLOW TO AID GROWTH
 
 
 
 
10.4.1.5
OTHER INSTRUMENTS
 
 
 
 
10.5
SOFTWARE & INFORMATICS
 
 
 
 
 
 
 
10.5.1
DEMAND FOR AI/ML CAPABILITIES WITH TOXICOLOGY DATA TO DRIVE GROWTH
 
 
 
 
11
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 79 Data Tables
 
 
 
 
 
181
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
ORGAN TOXICITY TESTING
 
 
 
 
 
 
 
11.2.1
HEPATOTOXICITY
 
 
 
 
 
 
 
11.2.1.1
REGULATORY MANDATES AND FOCUS ON DEVELOPING ADVANCED LIVER MODELS TO SUPPORT GROWTH
 
 
 
 
 
11.2.2
OCULAR TOXICITY
 
 
 
 
 
 
 
11.2.2.1
DEMAND FOR COSMETICS APPLICATION TO AID GROWTH
 
 
 
 
 
11.2.3
CARDIOTOXICITY
 
 
 
 
 
 
 
11.2.3.1
REGULATORY IMPERATIVE FOR COMPREHENSIVE CARDIAC SAFETY PROFILING TO DRIVE GROWTH
 
 
 
 
 
11.2.4
NEUROTOXICITY
 
 
 
 
 
 
 
11.2.4.1
FOCUS ON DEVELOPMENTAL NEUROTOXICITY AND THE EXPANDING CNS DRUG PIPELINES TO SUPPORT GROWTH
 
 
 
 
 
11.2.5
OTHER TOXICITY END POINTS
 
 
 
 
 
11.3
CYTOTOXICITY TESTING
 
 
 
 
 
 
 
11.3.1
A GROWING NUMBER OF NEW CLINICAL ENTITIES AND THE EXPANSION OF HTS PROGRAMS DRIVES MARKET
 
 
 
 
 
11.4
DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION
 
 
 
 
 
 
 
11.4.1
RISING AWARENESS AND BAN ON ANIMAL TESTING TO PROPEL MARKET
 
 
 
 
 
11.5
GENOTOXICITY TESTING
 
 
 
 
 
 
 
11.5.1
MANDATORY REQUIREMENT IN DRUG APPLICATIONS SUPPORTS MARKET GROWTH
 
 
 
 
 
11.6
OXIDATIVE STRESS AND MECHANISTIC TOXICITY
 
 
 
 
 
 
 
11.6.1
SHIFT TOWARD MECHANISTIC UNDERSTANDING TO DRIVE DEMAND FOR ASSAYS
 
 
 
 
 
11.7
OTHER TOXICITY ENDPOINTS & TESTS
 
 
 
 
 
12
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
 
 
 
 
 
216
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
CELL CULTURE TECHNOLOGIES
 
 
 
 
 
 
 
12.2.1
ADVANCING ADOPTION OF HUMAN-RELEVANT CELL CULTURE MODELS TO SUPPORT MARKET GROWTH
 
 
 
 
 
12.3
HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES
 
 
 
 
 
 
 
12.3.1
EXPANDING HIGH-THROUGHPUT TOXICITY SCREENING TO ACCELERATE EARLY SAFETY ASSESSMENT
 
 
 
 
 
12.4
ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES
 
 
 
 
 
 
 
12.4.1
GROWING FOCUS ON HUMAN-RELEVANT TOXICITY PREDICTION TO SUPPORT GROWTH
 
 
 
 
 
12.5
OMICS TECHNOLOGIES
 
 
 
 
 
 
 
12.5.1
INCREASING INTEGRATION OF OMICS-BASED TOXICOLOGY TO IMPROVE MECHANISTIC RISK ASSESSMENT
 
 
 
 
 
12.6
OTHER TECHNOLOGIES
 
 
 
 
 
13
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
232
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
CELL-BASED TOXICITY TESTING
 
 
 
 
 
 
 
13.2.1
CELL-BASED TOXICITY TESTING HOLDS LARGEST MARKET SHARE
 
 
 
 
 
13.3
BIOCHEMICAL TOXICITY TESTING METHOD
 
 
 
 
 
 
 
13.3.1
SPEED AND REPRODUCIBILITY TO AID GROWTH
 
 
 
 
 
13.4
MOLECULAR & OMICS-BASED TOXICOLOGY METHOD
 
 
 
 
 
 
 
13.4.1
TRANSITION FROM SINGLE-ENDPOINT TO SYSTEMS-LEVEL TOXICOLOGICAL ASSESSMENT DRIVES DEMAND GROWTH
 
 
 
 
 
13.5
EX VIVO MODEL-BASED TOXICITY TESTING METHOD
 
 
 
 
 
 
 
13.5.1
INCREASING AVAILABILITY OF HUMAN DONOR TISSUE TO SUPPORT ADOPTION
 
 
 
 
 
13.6
IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD
 
 
 
 
 
 
 
13.6.1
ESCALATING COST AND TIME PRESSURES OF PHYSICAL TESTING TO AID GROWTH
 
 
 
 
 
13.7
OTHER METHODS
 
 
 
 
 
14
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
253
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
14.2.1
RISING GLOBAL PHARMACEUTICAL R&D EXPENDITURE SUPPORTING DRUG DISCOVERY EFFORTS
 
 
 
 
 
14.3
CONSUMER CARE COMPANIES
 
 
 
 
 
 
 
14.3.1
ANIMAL TESTING BANS TO SUPPORT SEGMENT GROWTH
 
 
 
 
 
14.4
CROS
 
 
 
 
 
 
 
14.4.1
HIGH CAPITAL AND OPERATIONAL COSTS OF MAINTAINING ADVANCED TECHNOLOGIES SUPPORT OUTSOURCING TO CROS
 
 
 
 
 
14.5
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
14.5.1
INCREASING GOVERNMENT FUNDING FOR ALTERNATIVE TESTING RESEARCH TO AID GROWTH
 
 
 
 
 
14.6
FOOD & BEVERAGE COMPANIES
 
 
 
 
 
 
 
14.6.1
GROWTH OF FUNCTIONAL FOODS, PLANT-BASED PROTEINS, AND NOVEL INGREDIENTS DRIVES DEMAND FOR TESTING
 
 
 
 
 
14.7
OTHER END USERS
 
 
 
 
 
15
IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 58 Data Tables
 
 
 
 
 
276
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
TOXICOLOGY TESTING SERVICES
 
 
 
 
 
 
 
15.2.1
ORGAN-SPECIFIC TOXICITY SERVICES
 
 
 
 
 
 
 
15.2.1.1
HIGH RELIANCE ON OUTSOURCED SERVICES AND GROWING DEMAND FOR CARDIOTOXICITY TESTING TO DRIVE MARKET
 
 
 
 
 
15.2.2
CYTOTOXICITY TESTING SERVICES
 
 
 
 
 
 
 
15.2.2.1
GROWING PRECLINICAL PIPELINES REQUIRING CYTOTOXICITY TESTING TO PROPEL DEMAND
 
 
 
 
 
15.2.3
GENOTOXICITY TESTING SERVICES
 
 
 
 
 
 
 
15.2.3.1
EXPANDING IMPURITY TESTING OBLIGATIONS TO DRIVE MARKET
 
 
 
 
 
15.2.4
OTHER TOXICITY TESTING SERVICES
 
 
 
 
 
15.3
BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES
 
 
 
 
 
 
 
15.3.1
STRONG GROWTH SUPPORTED BY RISING DEMAND FOR APPLICATION-SPECIFIC MODELS AND ASSAYS
 
 
 
 
 
15.4
IMAGING & ANALYTICAL TOXICOLOGY SERVICES
 
 
 
 
 
 
 
15.4.1
CAPITAL-INTENSIVE INSTRUMENTATION AND SPECIALIZED REQUIREMENTS SUPPORT OUTSOURCING
 
 
 
 
 
15.5
DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY
 
 
 
 
 
 
 
15.5.1
INTEGRATION OF AI/ML AND RISING DATA COMPLEXITY PROPEL DEMAND
 
 
 
 
16
IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
302
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
CELL-BASED TOXICITY TESTING SERVICES
 
 
 
 
 
 
 
16.2.1
HIGH COST AND COMPLEXITY OF MAINTAINING ADVANCED CELL CULTURE INFRASTRUCTURE TO DRIVE GROWTH
 
 
 
 
 
16.3
BIOCHEMICAL TOXICITY TESTING SERVICES
 
 
 
 
 
 
 
16.3.1
GROWTH OF BIOLOGIC DRUG DEVELOPMENT IS DRIVING DEMAND FOR SPECIALIZED BIOCHEMICAL IMMUNOGENICITY TESTING SERVICES
 
 
 
 
 
16.4
IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES
 
 
 
 
 
 
 
16.4.1
GROWING DATA COMPLEXITY, AI/ML MATURITY, AND REGULATORY ACCEPTANCE DRIVE GROWTH
 
 
 
 
 
16.5
MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES
 
 
 
 
 
 
 
16.5.1
SPECIALIZED ANALYTICAL EXPERTISE REQUIREMENTS RELATED TO OMICS TO DRIVE GROWTH
 
 
 
 
 
16.6
EX VIVO MODEL-BASED TOXICITY TESTING SERVICES
 
 
 
 
 
 
 
16.6.1
USE OF EX VIVO MODELS FOR IN VITRO AND IN SILICO VALIDATION TO SUPPORT GROWTH
 
 
 
 
 
16.7
OTHER SERVICES
 
 
 
 
 
17
IN VITRO TOXICOLOGY TESTING SERVICE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
 
 
 
 
 
323
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
17.2.1
INCREASING COST AND COMPLEXITY OF MAINTAINING ADVANCED IVTT PLATFORMS IN-HOUSE TO SUPPORT GROWTH
 
 
 
 
 
17.3
CONSUMER CARE COMPANIES
 
 
 
 
 
 
 
17.3.1
REGULATION MANDATING IN VITRO-ONLY SAFETY ASSESSMENT IS SUPPORTING GROWTH
 
 
 
 
 
17.4
FOOD & BEVERAGE COMPANIES
 
 
 
 
 
 
 
17.4.1
EXPANDING SCOPE OF FUNCTIONAL FOOD AND ALTERNATIVE PROTEIN SAFETY ASSESSMENT TO SUPPORT GROWTH
 
 
 
 
 
17.5
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
17.5.1
OUTSOURCING OF SPECIALIZED SERVICES TO SUPPORT GROWTH
 
 
 
 
 
17.6
OTHER END USERS
 
 
 
 
 
18
IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 17 Countries | 427 Data Tables.
 
 
 
 
 
342
 
18.1
INTRODUCTION
 
 
 
 
 
 
18.2
NORTH AMERICA
 
 
 
 
 
 
 
18.2.1
US
 
 
 
 
 
 
 
18.2.1.1
GROWING FOCUS ON BIOMARKER DISCOVERY AND RESEARCH IN STRUCTURE-BASED DRUG DESIGN TO PROPEL THE MARKET
 
 
 
 
 
18.2.2
CANADA
 
 
 
 
 
 
 
18.2.2.1
STRONG SUPPORT FOR R&D IN PHARMACEUTICALS AND PROTEOMICS TO BOOST MARKET GROWTH
 
 
 
 
18.3
EUROPE
 
 
 
 
 
 
 
18.3.1
GERMANY
 
 
 
 
 
 
 
18.3.1.1
WELL-ESTABLISHED PHARMACEUTICALS INDUSTRY TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.2
UK
 
 
 
 
 
 
 
18.3.2.1
RISING FOCUS ON RESEARCH ACTIVITIES AND ACADEMIA-INDUSTRY PARTNERSHIPS TO DRIVE MARKET
 
 
 
 
 
18.3.3
FRANCE
 
 
 
 
 
 
 
18.3.3.1
INCREASING GOVERNMENT FUNDING FOR PROTEOMICS AND GENOMICS RESEARCH TO DRIVE MARKET
 
 
 
 
 
18.3.4
ITALY
 
 
 
 
 
 
 
18.3.4.1
INCREASING LIFE SCIENCES RESEARCH TO PROPEL MARKET
 
 
 
 
 
18.3.5
SPAIN
 
 
 
 
 
 
 
18.3.5.1
GROWING CHEMICALS INDUSTRY TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.3.6
REST OF EUROPE
 
 
 
 
 
18.4
ASIA PACIFIC
 
 
 
 
 
 
 
18.4.1
CHINA
 
 
 
 
 
 
 
18.4.1.1
INCREASING INTERNATIONAL PRESSURE TO BAN ANIMAL TESTING METHODS TO PROPEL THE MARKET
 
 
 
 
 
18.4.2
JAPAN
 
 
 
 
 
 
 
18.4.2.1
RISING DEMAND FOR TECHNOLOGICALLY ADVANCED RESEARCH PRODUCTS TO DRIVE MARKET
 
 
 
 
 
18.4.3
INDIA
 
 
 
 
 
 
 
18.4.3.1
GROWING FOCUS OF UNIVERSITIES ON AVOIDING ANIMAL TESTING FOR COSMETIC PRODUCTS TO PROPEL THE MARKET
 
 
 
 
 
18.4.4
SOUTH KOREA
 
 
 
 
 
 
 
18.4.4.1
GROWING GOVERNMENT FOCUS ON BOOSTING PHARMACEUTICAL SPENDING TO PROPEL MARKET GROWTH
 
 
 
 
 
18.4.5
AUSTRALIA
 
 
 
 
 
 
 
18.4.5.1
GROWING PHARMACEUTICAL RESEARCH TO HELP MARKET GROWTH
 
 
 
 
 
18.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
18.5
LATIN AMERICA
 
 
 
 
 
 
 
18.5.1
BRAZIL
 
 
 
 
 
 
 
18.5.1.1
ADOPTION OF NON-ANIMAL TESTING METHODS TO PROPEL MARKET
 
 
 
 
 
18.5.2
MEXICO
 
 
 
 
 
 
 
18.5.2.1
BAN ON ANIMAL TESTING FOR COSMETICS TO SUPPORT MARKET GROWTH
 
 
 
 
 
18.5.3
REST OF LATIN AMERICA
 
 
 
 
 
18.6
MIDDLE EAST
 
 
 
 
 
 
 
18.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
18.6.1.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
18.6.1.1.1
RISING PHARMACEUTICAL R&D ACTIVITIES AND REGULATORY FOCUS ON ALTERNATIVE TESTING METHODS TO SUPPORT MARKET GROWTH
 
 
 
 
18.6.1.2
UNITED ARAB EMIRATES (UAE)
 
 
 
 
 
 
 
 
18.6.1.2.1
EXPANDING BIOTECHNOLOGY ECOSYSTEM AND GROWING FOCUS ON ADVANCED SAFETY ASSESSMENT TECHNOLOGIES SUPPORTING MARKET GROWTH
 
 
 
 
18.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
 
18.6.1.4
REST OF MIDDLE EAST
 
 
 
 
 
18.6.2
AFRICA
 
 
 
 
 
 
 
18.6.2.1
PRECISION MEDICINE INITIATIVES TO FUEL MARKET GROWTH
 
 
 
19
COMPETITIVE LANDSCAPE
Gain insights on market leaders, emerging players, and strategic shifts reshaping in vitro toxicology testing.
 
 
 
 
 
550
 
19.1
OVERVIEW
 
 
 
 
 
 
19.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
19.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
19.3
REVENUE SHARE ANALYSIS
 
 
 
 
 
 
19.4
MARKET SHARE ANALYSIS
 
 
 
 
 
 
 
19.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
19.5.1
STARS
 
 
 
 
 
 
19.5.2
EMERGING LEADERS
 
 
 
 
 
 
19.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.5.4
PARTICIPANTS
 
 
 
 
 
 
19.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
19.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
19.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
19.5.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
19.5.5.4
TECHNOLOGY FOOTPRINT
 
 
 
 
19.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
19.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
19.6.2
STARTING BLOCKS
 
 
 
 
 
 
19.6.3
RESPONSIVE COMPANIES
 
 
 
 
 
 
19.6.4
DYNAMIC COMPANIES
 
 
 
 
 
 
19.6.5
COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
 
19.6.5.1
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
19.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
19.7.1
FINANCIAL METRICS
 
 
 
 
 
 
19.7.2
COMPANY VALUATION
 
 
 
 
 
19.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
19.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
19.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
19.9.2
DEALS
 
 
 
 
 
 
19.9.3
EXPANSIONS
 
 
 
 
20
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
569
 
20.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
20.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
 
20.1.1.1
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
20.1.1.2
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
20.1.1.2.1
PRODUCT LAUNCHES
 
 
 
 
 
 
20.1.1.2.2
DEALS
 
 
 
 
 
 
20.1.1.2.3
EXPANSIONS
 
 
 
 
20.1.1.3
MNM VIEW
 
 
 
 
 
 
 
 
20.1.1.3.1
KEY STRENGTHS
 
 
 
 
 
 
20.1.1.3.2
STRATEGIC CHOICES
 
 
 
 
 
 
20.1.1.3.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
20.1.2
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
20.1.3
MERCK KGAA
 
 
 
 
 
 
20.1.4
EUROFINS SCIENTIFIC
 
 
 
 
 
 
20.1.5
CHARLES RIVER LABORATORIES
 
 
 
 
 
 
20.1.6
LABORATORY CORPORATION OF AMERICA HOLDINGS
 
 
 
 
 
 
20.1.7
SGS SA
 
 
 
 
 
 
20.1.8
LONZA
 
 
 
 
 
 
20.1.9
REVVITY
 
 
 
 
 
 
20.1.10
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
20.1.11
EVOTEC SE
 
 
 
 
 
 
20.1.12
NOVO HOLDINGS
 
 
 
 
 
 
20.1.13
INTERTEK GROUP PLC
 
 
 
 
 
 
20.1.14
INOTIV
 
 
 
 
 
 
20.1.15
PROMEGA CORPORATION
 
 
 
 
 
20.2
OTHER PLAYERS
 
 
 
 
 
 
 
20.2.1
BIOIVT
 
 
 
 
 
 
20.2.2
CREATIVE BIOLABS
 
 
 
 
 
 
20.2.3
MEDICILON
 
 
 
 
 
 
20.2.4
CREATIVE BIOARRAY
 
 
 
 
 
 
20.2.5
ARAGEN LIFE SCIENCES LTD.
 
 
 
 
 
 
20.2.6
ENZO BIOCHEM INC.
 
 
 
 
 
 
20.2.7
MICROBAC LABORATORIES, INC.
 
 
 
 
 
 
20.2.8
VIMTA LABS LTD.
 
 
 
 
 
 
20.2.9
PACIFIC BIOLABS, INC.
 
 
 
 
 
 
20.2.10
MB RESEARCH LABORATORIES
 
 
 
 
21
RESEARCH METHODOLOGY
 
 
 
 
 
660
 
21.1
RESEARCH DATA
 
 
 
 
 
 
 
21.1.1
SECONDARY DATA
 
 
 
 
 
 
21.1.2
PRIMARY DATA
 
 
 
 
 
21.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
21.2.1
GLOBAL IN VITRO TOXICOLOGY TESTING MARKET ESTIMATION, 2025
 
 
 
 
 
 
 
21.2.1.1
KEY INDUSTRY INSIGHTS
 
 
 
 
21.3
GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
 
 
 
 
 
 
21.4
MARKET BREAKDOWN AND DATA TRIANGULATION
 
 
 
 
 
 
21.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
21.6
RESEARCH LIMITATIONS
 
 
 
 
 
 
21.7
RISK ANALYSIS
 
 
 
 
 
22
APPENDIX
 
 
 
 
 
673
 
22.1
DISCUSSION GUIDE
 
 
 
 
 
 
22.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
22.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
22.4
RELATED REPORTS
 
 
 
 
 
 
22.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
IN VITRO TOXICOLOGY TESTING MARKET: IMPACT ANALYSIS
 
 
 
 
 
 
TABLE 2
IN VITRO TOXICOLOGY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
IN VITRO TOXICOLOGY TESTING MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
 
 
 
 
 
 
TABLE 5
INDICATIVE SELLING PRICE, BY REGION, 2025
 
 
 
 
 
 
TABLE 6
IN VITRO TOXICOLOGY TESTING MARKET: KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 7
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 8
INDICATIVE LIST OF PATENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2026
 
 
 
 
 
 
TABLE 9
CASE STUDIES OF AI IMPLEMENTATION IN IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
TABLE 10
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 12
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 13
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 14
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 15
COUNTRY-WISE REGULATORY SCENARIO FOR IN VITRO TOXICOLOGY TESTING PRODUCT & SERVICE PROVIDERS
 
 
 
 
 
 
TABLE 16
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
 
 
TABLE 17
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
TABLE 18
IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 19
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY REGION, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 20
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 21
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 22
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 23
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 24
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY REGION, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 25
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 26
IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 27
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 28
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 29
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 30
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 31
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 32
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031(USD MILLION)
 
 
 
 
 
 
TABLE 33
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
IVTT REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
NORTH AMERICA: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
EUROPE: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
ASIA PACIFIC: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
LATIN AMERICA: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
MIDDLE EAST: IVTT REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
GCC COUNTRIES: IVTT REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
IVTT REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
NORTH AMERICA: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
EUROPE: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
ASIA PACIFIC: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
LATIN AMERICA: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
MIDDLE EAST: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
GCC COUNTRIES: CULTURE REAGENTS, MEDIA, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
3D MODELS & TISSUE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
NORTH AMERICA: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
EUROPE: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
ASIA PACIFIC: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
LATIN AMERICA: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
MIDDLE EAST: 3D MODELS & TISSUE SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
GCC COUNTRIES: 3D MODELS & TISSUE SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
CELL LINES & PRIMARY CELLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
NORTH AMERICA: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
EUROPE: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
ASIA PACIFIC: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
LATIN AMERICA: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
MIDDLE EAST: CELL LINES & PRIMARY CELLS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
GCC COUNTRIES: CELL LINES & PRIMARY CELLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
IVTT ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
NORTH AMERICA: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
EUROPE: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
ASIA PACIFIC: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
LATIN AMERICA: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
MIDDLE EAST: IVTT ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
GCC COUNTRIES: IVTT ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
IVTT ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
NORTH AMERICA: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
EUROPE: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
ASIA PACIFIC: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
LATIN AMERICA: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
MIDDLE EAST: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
GCC COUNTRIES: ORGAN-SPECIFIC TOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
EUROPE: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
GENOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
EUROPE: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
ASIA PACIFIC: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
LATIN AMERICA: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
MIDDLE EAST: GENOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
GCC COUNTRIES: GENOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
OTHER ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
MIDDLE EAST: OTHER ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
GCC COUNTRIES: OTHER ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
IVTT EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
NORTH AMERICA: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
EUROPE: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
ASIA PACIFIC: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
LATIN AMERICA: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
MIDDLE EAST: IVTT EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
GCC COUNTRIES: IVTT EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
IVTT EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
NORTH AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
DETECTION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
NORTH AMERICA: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
EUROPE: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
ASIA PACIFIC: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
LATIN AMERICA: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
MIDDLE EAST: DETECTION INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
GCC COUNTRIES: DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
EUROPE: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
LATIN AMERICA: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
MIDDLE EAST: IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
GCC COUNTRIES: IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
OTHER INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
IVTT SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
NORTH AMERICA: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
EUROPE: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
ASIA PACIFIC: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
LATIN AMERICA: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
MIDDLE EAST: IVTT SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
GCC COUNTRIES: IVTT SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
ORGAN TOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
NORTH AMERICA: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
EUROPE: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
HEPATOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
NORTH AMERICA: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
EUROPE: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
ASIA PACIFIC: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
LATIN AMERICA: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
MIDDLE EAST: HEPATOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
GCC COUNTRIES: HEPATOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
OCULAR TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
NORTH AMERICA: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
EUROPE: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
ASIA PACIFIC: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
LATIN AMERICA: OCULAR TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
MIDDLE EAST: OCULAR TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
GCC COUNTRIES: OCULAR TOXICITY MARKET, BY COUNTRY , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
CARDIOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
NORTH AMERICA: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
EUROPE: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
ASIA PACIFIC: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
LATIN AMERICA: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
MIDDLE EAST: CARDIOTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
GCC COUNTRIES: CARDIOTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
NEUROTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
NORTH AMERICA: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
EUROPE: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
ASIA PACIFIC: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
LATIN AMERICA: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
MIDDLE EAST: NEUROTOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
GCC COUNTRIES: NEUROTOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
OTHER TOXICITY END POINTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
NORTH AMERICA: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
EUROPE: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
ASIA PACIFIC: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
LATIN AMERICA: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
MIDDLE EAST: OTHER TOXICITY END POINTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
GCC COUNTRIES: OTHER TOXICITY END POINTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
CYTOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
NORTH AMERICA: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
EUROPE: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
ASIA PACIFIC: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
LATIN AMERICA: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
MIDDLE EAST: CYTOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
GCC COUNTRIES: CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
NORTH AMERICA: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
EUROPE: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
ASIA PACIFIC: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
LATIN AMERICA: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
MIDDLE EAST: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
GCC COUNTRIES: DERMAL TOXICITY & SKIN IRRITATION, CORROSION, AND SENSITIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
GENOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
NORTH AMERICA: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
EUROPE: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
ASIA PACIFIC: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
LATIN AMERICA: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
MIDDLE EAST: GENOTOXICITY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
GCC COUNTRIES: GENOTOXICITY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
NORTH AMERICA: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
EUROPE: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
ASIA PACIFIC: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
LATIN AMERICA: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
MIDDLE EAST: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
GCC COUNTRIES: OXIDATIVE STRESS AND MECHANISTIC TOXICITY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
NORTH AMERICA: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
EUROPE: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
ASIA PACIFIC: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
LATIN AMERICA: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
MIDDLE EAST: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
GCC COUNTRIES: OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
CELL CULTURE TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
NORTH AMERICA: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
EUROPE: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
ASIA PACIFIC: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
LATIN AMERICA: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
MIDDLE EAST: CELL CULTURE TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
GCC COUNTRIES: CELL CULTURE TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
NORTH AMERICA: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
EUROPE: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
ASIA PACIFIC: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
LATIN AMERICA: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
MIDDLE EAST: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
GCC COUNTRIES: HIGH-THROUGHPUT & HIGH-CONTENT TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
NORTH AMERICA: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
EUROPE: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
ASIA PACIFIC: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
LATIN AMERICA: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
MIDDLE EAST: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
GCC COUNTRIES: ORGANOTYPIC & MICROPHYSIOLOGICAL-BASED TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
OMICS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
NORTH AMERICA: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
EUROPE: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
ASIA PACIFIC: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
LATIN AMERICA: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
MIDDLE EAST: OMICS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
GCC COUNTRIES: OMICS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
OTHER TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
CELL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
NORTH AMERICA: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
EUROPE: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
ASIA PACIFIC: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
LATIN AMERICA: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
MIDDLE EAST: CELL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
GCC COUNTRIES: CELL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
NORTH AMERICA: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
EUROPE: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
ASIA PACIFIC: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
LATIN AMERICA: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
MIDDLE EAST: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
GCC COUNTRIES: BIOCHEMICAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
NORTH AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
EUROPE: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
ASIA PACIFIC: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
LATIN AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
MIDDLE EAST: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
GCC COUNTRIES: MOLECULAR & OMICS-BASED TOXICOLOGY METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
NORTH AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
EUROPE: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
ASIA PACIFIC: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
LATIN AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
MIDDLE EAST: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
GCC COUNTRIES: EX VIVO MODEL-BASED TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
NORTH AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
EUROPE: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
ASIA PACIFIC: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
LATIN AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
MIDDLE EAST: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
GCC COUNTRIES: IN SILICO/COMPUTATIONAL TOXICITY TESTING METHOD MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
NORTH AMERICA: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
EUROPE: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
ASIA PACIFIC: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
LATIN AMERICA: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
MIDDLE EAST: OTHER IN VITRO TOXICOLOGY TESTING METHODS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
GCC COUNTRIES: OTHER METHODS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR CROS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
NORTH AMERICA: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
EUROPE: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
ASIA PACIFIC: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
LATIN AMERICA: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
MIDDLE EAST: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
GCC COUNTRIES: ORGAN-SPECIFIC TOXICITY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
CYTOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
NORTH AMERICA: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
EUROPE: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
ASIA PACIFIC: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
LATIN AMERICA: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
MIDDLE EAST: CYTOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
GCC COUNTRIES: CYTOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
GENOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
NORTH AMERICA: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
EUROPE: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
ASIA PACIFIC: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
LATIN AMERICA: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
MIDDLE EAST: GENOTOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
GCC COUNTRIES: GENOTOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
OTHER TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
NORTH AMERICA: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
EUROPE: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
ASIA PACIFIC: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
LATIN AMERICA: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
MIDDLE EAST: OTHER TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
GCC COUNTRIES: OTHER TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
NORTH AMERICA: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
EUROPE: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
ASIA PACIFIC: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
LATIN AMERICA: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
MIDDLE EAST: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
GCC COUNTRIES: BIOLOGICAL MODEL & ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
NORTH AMERICA: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
EUROPE: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
ASIA PACIFIC: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
LATIN AMERICA: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
MIDDLE EAST: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
GCC COUNTRIES: IMAGING & ANALYTICAL TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
NORTH AMERICA: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
EUROPE: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
ASIA PACIFIC: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
LATIN AMERICA: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
MIDDLE EAST: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
GCC COUNTRIES: DATA ANALYSIS, BIOINFORMATICS, AND PREDICTIVE TOXICOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
CELL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
NORTH AMERICA: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
EUROPE: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
ASIA PACIFIC: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
LATIN AMERICA: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
MIDDLE EAST: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
GCC COUNTRIES: CELL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
NORTH AMERICA: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
EUROPE: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
ASIA PACIFIC: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
LATIN AMERICA: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
MIDDLE EAST: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
GCC COUNTRIES: BIOCHEMICAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
NORTH AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
EUROPE: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
ASIA PACIFIC: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
LATIN AMERICA: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
MIDDLE EAST: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
GCC COUNTRIES: IN SILICO/COMPUTATIONAL TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
NORTH AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
EUROPE: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
ASIA PACIFIC: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
LATIN AMERICA: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
MIDDLE EAST: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
GCC COUNTRIES: MOLECULAR & OMICS-BASED TOXICOLOGY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
NORTH AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
EUROPE: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
ASIA PACIFIC: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
LATIN AMERICA: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
MIDDLE EAST: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
GCC COUNTRIES: EX VIVO MODEL-BASED TOXICITY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
NORTH AMERICA: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
EUROPE: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
ASIA PACIFIC: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
LATIN AMERICA: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
MIDDLE EAST: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
GCC COUNTRIES: OTHER IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR CONSUMER CARE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
NORTH AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
NORTH AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
NORTH AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
US: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
US: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
US: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
US: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
US: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
US: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
US: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
US: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
US: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
CANADA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
CANADA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
CANADA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
CANADA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
CANADA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
CANADA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
CANADA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
CANADA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
EUROPE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
EUROPE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
EUROPE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
GERMANY: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
GERMANY: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
GERMANY: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
GERMANY: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
GERMANY: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
GERMANY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
GERMANY: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
GERMANY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
UK: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
UK: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
UK: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
UK: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
UK: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
UK: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
UK: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
UK: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
UK: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
FRANCE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
FRANCE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
FRANCE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
FRANCE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
FRANCE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
FRANCE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
FRANCE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
FRANCE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
ITALY: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
ITALY: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
ITALY: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
ITALY: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
ITALY: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
ITALY: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
ITALY: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
ITALY: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
SPAIN: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
SPAIN: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
SPAIN: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
SPAIN: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 631
SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 632
SPAIN: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 633
SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 634
SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 635
SPAIN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 636
SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 637
SPAIN: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 638
SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 639
SPAIN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 640
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 641
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 642
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 643
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 644
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 645
REST OF EUROPE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 646
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 647
REST OF EUROPE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 648
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 649
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 650
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 651
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 652
REST OF EUROPE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 653
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 654
REST OF EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 655
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 656
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 657
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 658
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 659
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 660
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 661
ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 662
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 663
ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 664
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 665
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 666
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 667
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 668
ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 669
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 670
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 671
CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 672
CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 673
CHINA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 674
CHINA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 675
CHINA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 676
CHINA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 677
CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 678
CHINA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 679
CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 680
CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 681
CHINA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 682
CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 683
CHINA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 684
CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 685
CHINA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 686
JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 687
JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 688
JAPAN: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 689
JAPAN: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 690
JAPAN: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 691
JAPAN: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 692
JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 693
JAPAN: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 694
JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 695
JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 696
JAPAN: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 697
JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 698
JAPAN: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 699
JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 700
JAPAN: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 701
INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 702
INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 703
INDIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 704
INDIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 705
INDIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 706
INDIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 707
INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 708
INDIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 709
INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 710
INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 711
INDIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 712
INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 713
INDIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 714
INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 715
INDIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 716
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 717
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 718
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 719
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 720
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 721
SOUTH KOREA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 722
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 723
SOUTH KOREA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 724
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 725
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 726
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 727
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 728
SOUTH KOREA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 729
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 730
SOUTH KOREA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 731
AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 732
AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 733
AUSTRALIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 734
AUSTRALIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 735
AUSTRALIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 736
AUSTRALIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 737
AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 738
AUSTRALIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 739
AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 740
AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 741
AUSTRALIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 742
AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 743
AUSTRALIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 744
AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 745
AUSTRALIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 746
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 747
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 748
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 749
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 750
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 751
REST OF ASIA PACIFIC: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 752
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 753
REST OF ASIA PACIFIC: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 754
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 755
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 756
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 757
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 758
REST OF ASIA PACIFIC: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 759
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 760
REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 761
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 762
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 763
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 764
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 765
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 766
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 767
LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 768
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 769
LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 770
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 771
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 772
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 773
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 774
LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 775
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 776
LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 777
BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 778
BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 779
BRAZIL: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 780
BRAZIL: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 781
BRAZIL: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE , 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 782
BRAZIL: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 783
BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 784
BRAZIL: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 785
BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 786
BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 787
BRAZIL: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 788
BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 789
BRAZIL: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 790
BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 791
BRAZIL: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 792
MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 793
MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 794
MEXICO: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 795
MEXICO: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 796
MEXICO: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 797
MEXICO: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 798
MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 799
MEXICO: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 800
MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 801
MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 802
MEXICO: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 803
MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 804
MEXICO: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 805
MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 806
MEXICO: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 807
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 808
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 809
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 810
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 811
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 812
REST OF LATIN AMERICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 813
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 814
REST OF LATIN AMERICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 815
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET , BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 816
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 817
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 818
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 819
REST OF LATIN AMERICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 820
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 821
REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 822
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 823
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 824
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 825
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 826
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 827
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 828
MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 829
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 830
MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 831
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 832
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 833
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 834
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 835
MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 836
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 837
MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 838
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 839
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 840
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 841
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 842
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 843
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 844
GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 845
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 846
GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 847
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 848
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 849
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 850
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 851
GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 852
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 853
GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 854
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 855
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 856
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 857
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 858
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 859
SAUDI ARABIA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 860
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 861
SAUDI ARABIA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 862
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 863
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 864
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 865
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 866
SAUDI ARABIA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 867
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 868
SAUDI ARABIA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 869
UAE: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 870
UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 871
UAE: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 872
UAE: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 873
UAE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 874
UAE: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 875
UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 876
UAE: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 877
UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 878
UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 879
UAE: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 880
UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 881
UAE: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 882
UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 883
UAE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 884
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 885
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 886
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 887
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 888
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 889
REST OF GCC COUNTRIES: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 890
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET , BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 891
REST OF GCC COUNTRIES: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 892
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 893
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 894
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 895
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 896
REST OF GCC COUNTRIES: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 897
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 898
REST OF GCC COUNTRIES: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 899
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 900
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 901
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 902
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 903
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 904
REST OF MIDDLE EAST: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 905
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 906
REST OF MIDDLE EAST: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 907
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 908
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 909
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 910
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 911
REST OF MIDDLE EAST: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 912
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 913
REST OF MIDDLE EAST: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 914
AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 915
AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 916
AFRICA: IN VITRO TOXICOLOGY TESTING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 917
AFRICA: IN VITRO TOXICOLOGY TESTING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 918
AFRICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 919
AFRICA: DETECTION, IMAGING, AND ANALYTICAL SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 920
AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TOXICITY ENDPOINT & TEST, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 921
AFRICA: ORGAN TOXICITY TESTING MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 922
AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 923
AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 924
AFRICA: IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 925
AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 926
AFRICA: TOXICOLOGY TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 927
AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY METHOD, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 928
AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 929
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
TABLE 930
IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 931
IN VITRO TOXICOLOGY TESTING MARKET: REGION FOOTPRINT (2025)
 
 
 
 
 
 
TABLE 932
IN VITRO TOXICOLOGY TESTING MARKET: OFFERING FOOTPRINT (2025)
 
 
 
 
 
 
TABLE 933
IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET: TECHNOLOGY FOOTPRINT (2025
 
 
 
 
 
 
TABLE 934
IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 935
IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION
 
 
 
 
 
 
TABLE 936
IN VITRO TOXICOLOGY TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 937
HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 938
HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 939
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 940
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 941
THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 942
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 943
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 944
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 945
AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 946
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 947
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 948
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 949
MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 950
MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 951
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 952
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 953
EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 954
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 955
CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 956
CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 957
CHARLES RIVER LABORATORIES: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 958
CHARLES RIVER LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 959
LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 960
LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 961
LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 962
LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 963
LABORATORY CORPORATION OF AMERICA HOLDINGS: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 964
SGS SA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 965
SGS SA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 966
SGS SA: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 967
SGS SA: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 968
LONZA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 969
LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 970
REVVITY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 971
REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 972
REVVITY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 973
REVVITY: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 974
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 975
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 976
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 977
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 978
EVOTEC SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 979
EVOTEC SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 980
EVOTEC SE: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 981
LABORATORY CORPORATION OF AMERICA HOLDINGS: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 982
NOVO HOLDINGS: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 983
INTERTEK GROUP PLC: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 984
INOTIV: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 985
PROMEGA CORPORATION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 986
PROMEGA CORPORATION: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 987
BIOIVT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 988
CREATIVE BIOLABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 989
MEDICILON: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 990
CREATIVE BIOARRAY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 991
ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 992
ENZO BIOCHEM INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 993
MICROBAC LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 994
VIMTA LABS LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 995
PACIFIC BIOLABS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 996
MB RESEARCH LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 997
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 2
GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 4
DISRUPTIONS INFLUENCING THE GROWTH OF IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
FIGURE 5
HIGH-GROWTH SEGMENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
SHIFT TOWARDS NON-ANIMAL TOXICOLOGY TESTING METHODS TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 8
REAGENTS & CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING PRODUCTS MARKET IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 9
ASIA PACIFIC IS LIKELY TO BE THE FASTEST-GROWING REGIONAL MARKET DURING THE FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 12
IN VITRO TOXICOLOGY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 13
IN VITRO TOXICOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 14
IN VITRO TOXICOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 15
IN VITRO TOXICOLOGY TESTING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 16
TOP APPLICANTS/OWNERS (COMPANIES) FOR IN VITRO TOXICOLOGY TESTING PATENTS, 2015–2025
 
 
 
 
 
 
FIGURE 17
IMPACT OF AI/GEN AI ON IN VITRO TOXICOLOGY TESTING MARKET
 
 
 
 
 
 
FIGURE 18
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 19
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 20
NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 21
ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 23
IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2025
 
 
 
 
 
 
FIGURE 24
IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 25
IN VITRO TOXICOLOGY TESTING MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 26
IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 27
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 28
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 29
IN VITRO TOXICITY TESTING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 30
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 31
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 32
MERCK KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 33
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 34
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 35
LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 36
SGS SA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
LONZA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
REVVITY: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
EVOTEC SE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
INTERTEK GROUP PLC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
INOTIV: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 44
IN VITRO TOXICOLOGY TESTING MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 45
IN VITRO TOXICOLOGY TESTING: MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 46
MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 47
ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2025
 
 
 
 
 
 
FIGURE 48
IVTT MARKET: INSIGHTS FROM PRIMARIES
 
 
 
 
 
 
FIGURE 49
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 50
IN VITRO TOXICOLOGY TESTING MARKET: CAGR PROJECTIONS
 
 
 
 
 
 
FIGURE 51
IN VITRO TOXICOLOGY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
 
 
 
 
 
 
FIGURE 52
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global in vitro toxicology testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the in vitro toxicology testing market. Secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), The Lens, American Society for Testing and Materials (ASTM), Center for Alternatives to Animal Testing (CAAT), European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), National Institute of Environmental Health Sciences (NIEHS), Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC), United States Environmental Protection Agency (USEPA), US Food and Drug Administration (US FDA), US Census Bureau, Eurostat, Statista, and Factiva. The Scientist Magazine, ScienceDirect, research journals, corporate filings such as annual reports, SEC filings, investor presentations, and financial statements, press releases, trade, business, professional associations and others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

In Vitro Toxicology Testing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the in vitro toxicology testing market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market.

In Vitro Toxicology Testing Market Top Down and Bottom Up Approach

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.

Market Definition

Toxicology/Toxicity testing is required to evaluate compounds to identify their potential adverse effects to assure safety for human and environmental use. In vitro toxicology testing is ideally suited for the investigation of molecular, cellular, and physiological mechanisms of chemically induced toxicity, which cannot readily be studied in vivo. In vitro toxicology testing is widely used by pharmaceutical and biopharmaceutical, consumer care, food, and other industries.

Key Stakeholders

  • Academic Research Institutes
  • Biotechnology Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Chemical Companies
  • Medical Device Companies
  • Food & Beverage Manufacturers
  • Contract Research Organizations (CROs)
  • Market Research & Consulting Firms
  • Venture Capitalists & Investors
  • Government Associations

Report Objectives

  • To define, describe, and forecast the in vitro toxicology testing market by offering, product type, toxicity end point and test, technology, method, end user, service type, method, end user, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall in vitro toxicology testing market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), Middle East [GCC (Saudi Arabia, United Arab Emirates, and the Rest of GCC) and the Rest of Middle East], and Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product/ service launches, partnerships, agreements, acquisitions, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the Rest of Europe in vitro toxicology testing market, by country
  • Further breakdown of the Rest of Asia Pacific in vitro toxicology testing market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Cross-segment analysis

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the In Vitro Toxicology Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in In Vitro Toxicology Testing Market

James

Oct, 2021

Thanks for this amazing information. keep posting it. .

Harrison

Oct, 2022

In what way the global In Vitro Toxicology Testing Market is impacted by the COVID19?.

DMCA.com Protection Status